Loading viewer...
investor_presentation
Format: PDF investor_presentation
ImmuCell Corporation (NASDAQ: ICCC) is a biotechnology company developing and commercializing products for the dairy and beef industries. The August 2022 presentation covers the company's strategic opportunities, product pipeline including First Defense and Re-Tain, and financial performance amid supply chain challenges and inflationary pressures.
investor_presentation
52 Pages
investor_presentation
13 Pages
Vertex Pharmaceuticals
Mid-America Apartment Communities Investor Presentation — March 2021
investor_presentationinvestor_presentation
31 Pages
Mid-America Apartment Communities
Lincoln National Corporation Investor Presentation 2023
investor_presentationinvestor_presentation
26 Pages
Lincoln National Corporation